These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2024969)

  • 1. Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus.
    Yoshida S; Kojima T; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1991 Feb; 35(2):368-70. PubMed ID: 2024969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of 3H-norfloxacin in methicillin-resistant Staphylococcus aureus.
    Cundy KV; Fasching CE; Willard KE; Peterson LR
    J Antimicrob Chemother; 1991 Oct; 28(4):491-7. PubMed ID: 1761443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus.
    Takenouchi T; Tabata F; Iwata Y; Hanzawa H; Sugawara M; Ohya S
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1835-42. PubMed ID: 8843290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial activity of a new tetracyclic quinolone, No. 5290, against norfloxacin- and ciprofloxacin-resistant strains of Staphylococcus aureus.
    Kotera Y; Inoue Y; Ohashi M; Ito K; Tsukamoto G
    Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2644-6. PubMed ID: 1666861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of effect of carbonyl cyanide m-chlorophenylhydrazone on KB-5246 accumulation by Staphylococcus aureus.
    Kotera Y; Inoue Y; Ohashi M; Ito K; Inoue M
    Antimicrob Agents Chemother; 1992 Apr; 36(4):883-5. PubMed ID: 1323957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on uptake of fluoroquinolones by Staphylococcus aureus].
    Zhong L; Feng P; Xia P; Lei B; Fan X; Lü X
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Mar; 31(1):18-20. PubMed ID: 12501602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Accumulation and efflux of quinolones by clinical isolates of Stenotrophomonas maltophilia].
    Sánchez P; Alonso A; Campanario E; Alós I; Martíinez JL
    Rev Esp Quimioter; 2000 Jun; 13(2):176-81. PubMed ID: 10918091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome.
    Ng EY; Trucksis M; Hooper DC
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1345-55. PubMed ID: 8092836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of 4-quinolone resistance in quinolone-resistant and methicillin-resistant Staphylococcus aureus isolates from Japan and China.
    Tanaka M; Zhang YX; Ishida H; Akasaka T; Sato K; Hayakawa I
    J Med Microbiol; 1995 Mar; 42(3):214-9. PubMed ID: 7884804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of clinical resistance to fluoroquinolones in Staphylococcus aureus.
    Nakanishi N; Yoshida S; Wakebe H; Inoue M; Yamaguchi T; Mitsuhashi S
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2562-7. PubMed ID: 1667255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus.
    Schmitz FJ; Fluit AC; Lückefahr M; Engler B; Hofmann B; Verhoef J; Heinz HP; Hadding U; Jones ME
    J Antimicrob Chemother; 1998 Dec; 42(6):807-10. PubMed ID: 10052906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aerobic and anaerobic environments on antistaphylococcal activities of five fluoroquinolones.
    Zabinski RA; Walker KJ; Larsson AJ; Moody JA; Kaatz GW; Rotschafer JC
    Antimicrob Agents Chemother; 1995 Feb; 39(2):507-12. PubMed ID: 7726522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between the activity of different fluoroquinolones and the presence of mechanisms of quinolone resistance in epidemiologically related and unrelated strains of methicillin-susceptible and -resistant Staphylococcus aureus.
    Sierra JM; Marco F; Ruiz J; Jiménez de Anta MT; Vila J
    Clin Microbiol Infect; 2002 Dec; 8(12):781-90. PubMed ID: 12519351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolone-susceptible Staphylococcus aureus.
    Furet YX; Deshusses J; Pechère JC
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2506-11. PubMed ID: 1489194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Energy-dependent accumulation of norfloxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relationship to extended-spectrum beta-lactamase production.
    Martínez-Martínez L; Pascual A; Conejo Mdel C; García I; Joyanes P; Doménech-Sánchez A; Benedí VJ
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3926-32. PubMed ID: 12435697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A convenient assay for estimating the possible involvement of efflux of fluoroquinolones by Streptococcus pneumoniae and Staphylococcus aureus: evidence for diminished moxifloxacin, sparfloxacin, and trovafloxacin efflux.
    Beyer R; Pestova E; Millichap JJ; Stosor V; Noskin GA; Peterson LR
    Antimicrob Agents Chemother; 2000 Mar; 44(3):798-801. PubMed ID: 10681364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Smith KR; Cobbs CG
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):55-8. PubMed ID: 1314175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of eight fluoroquinolones against both methicillin-susceptible and -resistant Staphylococcus aureus isolated from skin infections.
    Nishijima S; Namura S; Akamatsu H; Kawai S; Asada Y; Kawabata S; Fujita M
    J Dermatol; 1995 Feb; 22(2):153-5. PubMed ID: 7722093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro activity of new sulphanilil fluoroquinolones against Staphylococcus aureus.
    Allemandi DA; Alovero FL; Manzo RH
    J Antimicrob Chemother; 1994 Aug; 34(2):261-5. PubMed ID: 7814287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus.
    Mortimer PG; Piddock LJ
    J Antimicrob Chemother; 1991 Nov; 28(5):639-53. PubMed ID: 1663928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.